This official launch marks the publication of the report of the EASL–Lancet Liver Commission:  Protecting the next generation of Europeans against liver disease complications and premature mortality. This prestigious event is a culmination of many years of collaboration together, with a new momentum toward its solid implementation. The discussion will engage commissioners (contributors to the report), other high-level actors and experts from the European institutions, and patient representatives. Key topics of the report will be discussed, as well as how the European Union policy and funding initiatives can support both the recommendations and application of good practices throughout the EU.

The goal of saving the lives of almost 300,000 people per year across Europe is what is driving this initiative. Policy actions for marketing, pricing, and taxation of alcohol and unhealthy foods are of paramount importance with an ability to reduce premature morbidity and save these hundreds of thousands of lives per year across the region.

Target audience

We warmly invite a broad range of stakeholders including primary care physiciansnursespatientspeers, and members of relevant communities, along with medical specialists trained in obesity, diabetesliver diseaseoncologycardiovascular diseasepublic healthaddictionsinfectious diseasescivil society organisations, representatives from patient organisationspolicymakersmedical associations, and other actors involved in those topics in Europe and beyond.

Time Title

Opening remarks

Patrizia Burra (Italy) and Thomas Berg, EASL Secretary-General (Germany)


Introductory remarks

Richard Horton, Editor-in-Chief, The Lancet (United Kingdom)


Keynote statement on EU health policy

Ursula von der Leyen, President of the European Commission (Belgium)


Overview of the EASL-Lancet Liver Commission

Michael Manns, EASL–Lancet Commission Co-chair (Germany)


The burden of liver disease in Europe

Nick Sheron (United Kingdom)


Children and the power of digital marketing

Shira Zelber-Sagi (Israel)


Stigma as a barrier in pathways of liver care

Patrizia Carrieri (France)


Primary care hepatology

Rachel Pryke (United Kingdom)


A paradigm shift in hepatology

Pere Ginès (Spain)


Panel discussion: How to move from recommendations to action?

Jeffrey Lazarus, EASL-Lancet Commissioner (Spain) &
Maria Buti, EASL EU Policy Councillor (Spain)

Shlomo Vinker, WONCA (Israel)
Michele Cecchini, OECD (France)
Rachel Halford, WHA (United Kingdom)


Q&A from audience


Future opportunities of a Lancet Commission

Sabine Kleinert, The Lancet (United Kingdom)


Closing remarks

Tom Hemming Karlsen, EASL–Lancet Commission Co-chair (Norway)


Ursula von der Leyen

Thomas Berg

Patrizia Burra

Maria Buti

Patrizia Carrieri

Ursula von der Leyen
President of the European Commission

Prof. Thomas Berg
EASL Secretary General

Prof. Patrizia Burra
EASL-Lancet Commission co-chair
Prof. Maria Buti
EASL EU Policy Councillor
Prof. Patrizia Carrieri
EASL-Lancet Commissioner

Michele Cecchini

Pere Gines

Rachel Halford

Richard Horton

George Kalamitsis

Dr Michele Cecchini

Prof. Pere Gines
EASL-Lancet Commissioner

Rachel Halford
World Hepatitis Alliance European Board Member
Prof. Richard Horton
The Lancet - Editor-in-Chief
George Kalamitsis
Liver Patient International

Tom H. Karlsen

 Sabine Kleinert

Jeffrey Lazarus

Michael Manns

Nick Sheron

Prof. Tom H. Karlsen
EASL-Lancet Commission co-chair

Sabine Kleinert
The Lancet, Senior Executive Editor

Prof. Jeffrey Lazarus
EASL-Lancet Commissioner
Prof. Michael Manns
EASL-Lancet Commission co-chair
Prof. Nick Sheron
EASL Policy and Public Health Committee Member & EASL-Lancet Commissioner

Rachel Pryke

Shlomo Vinker

Shira Zelber-Sagi

Dr Rachel Pryke
EASL-Lancet Commissioner

Prof. Shlomo Vinker
World Organisation of Family Doctors (WONCA) 

Prof. Jeffrey Lazarus
EASL-Lancet Commissioner